Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monotherapy versus combination therapy for the treatment of chronic hepatitis B.

Expert opinion on investigational drugs - 1 Nov 2009

Carey Ivana, Harrison Phillip M

Abstract excerpt

BACKGROUND: Nucleos(t)ide analogues, active against hepatitis B polymerase, suppress viral replication and improve clinical outcome. However, the emergence of drug-resistant mutants can result in treatment failure. OBJECTIVES: We describe how the choice of first-line therapy is critical to long-term treatment success. METHODS: A review of current drug therapies is provided. RESULTS/CONCLUSIONS: Monotherapy with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Treatment Outcome

Share to Virus Replication

Source

Identifiers

PMID: 19852566
DOI: 10.1517/13543780903241599

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monotherapy versus combination therapy for the treatment of chronic hepatitis B.PMID 19852566Read ↗

Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial.Semantic proximity Read ↗

[Management of antiviral-resistant chronic hepatitis B virus infection].Semantic proximity Read ↗

Current developments in nucleoside/nucleotide analogues for hepatitis B.Semantic proximity Read ↗

Treatment for hepatitis B in patients with drug resistanceSemantic proximity Read ↗

Chronic hepatitis B therapy: available drugs and treatment guidelines.Semantic proximity Read ↗

Management of antiviral drug resistance in chronic hepatitis B.Semantic proximity Read ↗

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.Semantic proximity Read ↗

Comparative evaluation of long-term monotherapies & combination therapies in patients with chronic hepatitis B: A pilot study.Semantic proximity Read ↗

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.Semantic proximity Read ↗

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).Semantic proximity Read ↗

Antiviral resistance and hepatitis B therapy #Semantic proximity Read ↗

Treatment of chronic hepatitis B: Evolution over two decadesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.